Redhill Biopharma Ltd. (RDHL) Total Assets by Year
Redhill Biopharma Ltd. closed fiscal year 2025 with $25.3M in total assets, $21.1M in total liabilities and $4.3M in shareholder equity. This represents an increase of 40.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Redhill Biopharma Ltd. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RDHL Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.3M+40.5% | $18.0M-21.7% | $23.0M-85.5% | $158.9M-12.3% | $181.2M+0.5% | $180.2M+143.2% | $74.1M+18.7% | $62.4M+8.8% | $57.3M-22.7% | $74.2M | N/A |
| Total Liabilities | $21.1M-7.3% | $22.7M+8.3% | $21.0M-89.9% | $207.3M+20.3% | $172.3M+3.6% | $166.4M+1080.2% | $14.1M+25.6% | $11.2M-8.6% | $12.3M+6.7% | $11.5M | N/A |
| Total Equity | $4.3M+191.1% | -$4.7M-326.3% | $2.1M+104.3% | -$48.4M-645.4% | $8.9M-36.0% | $13.9M-76.9% | $60.0M+17.2% | $51.2M+13.6% | $45.1M-28.1% | $62.7M+4.4% | $60.1M |
RDHL Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'256-K/A | Q4'246-K/A | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q2'2210-Q | Q4'2110-K | Q2'2110-Q | Q4'2010-K | Q2'2010-Q | Q4'1910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.4M-16.6% | $18.0M-21.7% | $22.0M-37.1% | $23.0M-85.5% | $35.0M-79.1% | $158.9M-12.3% | $168.0M-17.5% | $181.2M+0.5% | $203.7M+22.4% | $180.2M+143.2% | $166.4M+234.8% | $74.1M+18.7% |
| Total Liabilities | $22.8M+3.8% | $22.7M+8.3% | $22.0M-30.4% | $21.0M-89.9% | $31.6M-82.5% | $207.3M+20.3% | $179.9M+3.3% | $172.3M+3.6% | $174.1M+32.1% | $166.4M+1080.2% | $131.8M+640.7% | $14.1M+25.6% |
| Total Equity | -$4.4M-7332.8% | -$4.7M-326.3% | $61K-98.2% | $2.1M+104.3% | $3.5M+129.1% | -$48.4M-645.4% | -$11.9M-140.4% | $8.9M-36.0% | $29.6M-14.5% | $13.9M-76.9% | $34.6M+8.4% | $60.0M+17.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Redhill Biopharma Ltd. financials
Frequently Asked Questions
What was Redhill Biopharma Ltd.'s total assets in fiscal year 2025?
Redhill Biopharma Ltd. closed fiscal year 2025 with $25.3M in total assets, $21.1M in total liabilities and $4.3M in shareholder equity.
How fast is Redhill Biopharma Ltd.'s total assets growing?
Redhill Biopharma Ltd. (RDHL) total assets rose by 40.5% year over year, from $18.0M to $25.3M in fiscal year 2025.
What was Redhill Biopharma Ltd.'s total assets in the most recent quarter?
Redhill Biopharma Ltd. (RDHL) reported $18.4M in total assets in Q2 2025. This represents a decrease of 16.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Redhill Biopharma Ltd. (RDHL) reported on that line in every period on record.